Matheus Correia Casotti,Débora Dummer Meira,Aléxia Stefani Siqueira Zetum,Camilly Victória Campanharo,Danielle Ribeiro Campos da Silva,Giulia Maria Giacinti,Iris Moreira da Silva,João Augusto Diniz Moura,Karen Ruth Michio Barbosa,Lorena Souza Castro Altoé,Lorena Souza Rittberg Mauricio,Luíza Santa Brígida de Barros Góes,Lyvia Neves Rebello Alves,Sarah Sophia Guedes Linhares,Vinícius do Prado Ventorim,Yasmin Moreto Guaitolini,Eldamária de Vargas Wolfgramm Dos Santos,Flavia Imbroisi Valle Errera,Sonia Groisman,Elizeu Fagundes de Carvalho,Flavia de Paula,Marcelo Victor Pires de Sousa,Pierre Basílio Almeida Fechine,Iuri Drumond Louro

Abstract:Cancer therapy is facing increasingly significant challenges, marked by a wide range of techniques and research efforts centered around somatic mutations, precision oncology, and the vast amount of big data. Despite this abundance of information, the quest to cure cancer often seems more elusive, with the "war on cancer" yet to deliver a definitive victory. A particularly pressing issue is the development of tumor treatment resistance, highlighting the urgent need for innovative approaches. Evolutionary, Quantum Biology and System Biology offer a promising framework for advancing experimental cancer research. By integrating theoretical studies, translational methods, and flexible multidisciplinary clinical research, there's potential to enhance current treatment strategies and improve outcomes for cancer patients. Establishing stronger links between evolutionary, quantum, entropy and chaos principles and oncology could lead to more effective treatments that leverage an understanding of the tumor's evolutionary dynamics, paving the way for novel methods to control and mitigate cancer. Achieving these objectives necessitates a commitment to multidisciplinary and interprofessional collaboration at the heart of both research and clinical endeavors in oncology. This entails dismantling silos between disciplines, encouraging open communication and data sharing, and integrating diverse viewpoints and expertise from the outset of research projects. Being receptive to new scientific discoveries and responsive to how patients react to treatments is also crucial. Such strategies are key to keeping the field of oncology at the forefront of effective cancer management, ensuring patients receive the most personalized and effective care. Ultimately, this approach aims to push the boundaries of cancer understanding, treating it as a manageable chronic condition, aiming to extend life expectancy and enhance patient quality of life.

Embracing cancer complexity: Hallmarks of systemic disease

Plenary Paper

Hallmarks of Cancer: New Dimensions.

Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy

Cancer is not a guest

Hallmarks of cancer—the new testament

Hallmarks of Cancer: The Next Generation

Hallmarks of cancer: of all cancer cells, all the time?

Building an Organ-Wide Macroscopic View of Cancer Hallmarks

Integrating Hallmarks of Cancer

The Epigenetic Hallmarks of Cancer

Phenotypic Plasticity and Cancer: A System Biology Perspective

Cancer neuroscience: State of the field, emerging directions

Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation

Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets.

Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies

Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science

Cancer as robust intrinsic state shaped by evolution: a key issues review

Blueprint for cancer research: Critical gaps and opportunities

Exploiting ecological principles to better understand cancer progression and treatment